Afya (AFYA) Reports Acquisition of Medicinae
Get Alerts AFYA Hot Sheet
Join SI Premium – FREE
Afya Limited, or Afya (NASDAQ: AFYA) today announced the acquisition of 100% of the total share capital of Medicinae, a leading Brazilian healthcare technology company that specializes in healthcare payments and financial services, through its wholly-owned subsidiary Afya Participações S.A.
The acquisition will expand Afya’s digital health services, as it offers a unique financial platform that allows healthcare professionals all over Brazil to manage receivables in an efficient and scalable way using FIDC (Receivables Investment Fund). Medicinae relieves a number of challenges in the healthcare payments industry, as reduces long payment cycles for professionals and consolidates financial information, improving the consumer financial experience.
“This acquisition will give us advantages to enhance our digital services offerings, as it solves healthcare professionals financial challenges. Combining Medicinae solution with Afya’s scale, we will be able to grow it faster and continue to offer the best suite of services for physicians in Brazil,” said Virgílio Gibbon, Afya’s CEO.
Medicinae has more than 1,420 registered users, R$ 76.0 million in annualized transactions and has gown 11x revenue since 2018.
The aggregate purchase price is R$ 5.6 million (Enterprise Value) of which 100% paid in cash as the date hereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Progress Software Corporation (PRGS) Issues Statement on a Possible Offer for MariaDB
- ContextLogic (WISH) Receives Stockholder Approval of Transaction with Qoo10
- HUB Cyber Security (HUBC) Strongly Responds To Dominion’s Misleading Lawsuit; Reaffirms Dedication To Expansion And Worldwide Customer Support
Create E-mail Alert Related Categories
Corporate News, Management Comments, Mergers and AcquisitionsRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!